Paratek Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Paratek Pharmaceuticals

03/08/2023 14:47

* Paratek Pharmaceuticals Inc  PRTK.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 31 cents per share.
    * Revenue rose 34.9% to $39.99 million from a year ago;
analysts
expected $33.85 million. 
    * Paratek Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 25 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Paratek Pharmaceuticals Inc shares had risen by 0.5% this
quarter and gained 18.7% so far this year.
    * The company reported a quarterly loss of $14.55 million.
    * Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $2.15 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 01:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.31          -0.25          Beat
 Mar. 31 2023      -0.42          -0.35          Beat
 Dec. 31 2022      0.09           -0.12          Missed
 Sep. 30 2022      -0.29          -0.38          Missed